Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
131,516,365
-
Total 13F shares
-
77,421,858
-
Share change
-
+3,299,138
-
Total reported value
-
$5,246,385,562
-
Put/Call ratio
-
56%
-
Price per share
-
$67.78
-
Number of holders
-
248
-
Value change
-
+$229,962,625
-
Number of buys
-
107
-
Number of sells
-
99
Institutional Holders of ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) as of Q3 2016
As of 30 Sep 2016 ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) had 248 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 77,421,858 shares of stock of the company.
Largest 10 holders included FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, DODGE & COX, PRICE T ROWE ASSOCIATES INC /MD/, BAILLIE GIFFORD & CO, STATE STREET CORP, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., and UBS ASSET MANAGEMENT AMERICAS INC.
This table shows 248 institutional shareholders of the security as of 30 Sep 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.